Studies genes linked to problems after heart surgery
Looks for genetic causes of complications, such as atrial fibrillation, after heart surgery.
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, Dallas, and Houston, United StatesSee the 3 sites
- Trial code
- Registry title
- Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- Aug 2000
- Expected to end
- Aug 2030
- Type of study
- Observational
- Record updated
- 22 August 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having heart surgery at Brigham and Women's Hospital or Texas Heart Institute. It studies genes that may cause problems after heart surgery.
- Age
- 20 Years to 90 Years
- Sex
- All sexes can join.
- Disease stage
- People who are having heart surgery.
Main reasons for not taking part
- Being enrolled in another drug or device trial that does not allow joining a second trial
- Not willing to give consent
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Undergoing heart surgery
- Willing to provide consent
Who cannot take part
- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Where in United States
- Brigham and Women's HospitalBoston, United StatesNo longer taking part
- UT Southwestern Medical CenterDallas, United StatesContact: Amanda A Fox, MDTaking people
- Department Texas Heart Institute at St. Luke's Episcopal HospitalHouston, United StatesNo longer taking part
About the trial
What the trial wants to find out
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.
Read full original descriptionShow less
Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
The group in the trial
- Cardiac surgery
Adult patients undergoing cardiac surgery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
- Plain-language title
- Studies genes linked to problems after heart surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Criteria questions
- Built from NCT01258231, who can take part
- Record updated
- 22 August 2024